Operation / Office Manager
迪哲(江苏)医药有限公司
- 公司规模:150-500人
- 公司性质:合资
- 公司行业:制药/生物工程
职位信息
- 发布日期:2020-10-14
- 工作地点:上海-浦东新区
- 招聘人数:1人
- 工作经验:10年以上经验
- 学历要求:本科
- 语言要求:英语精通
- 职位月薪:1.5-2万/月
- 职位类别:行政经理/主管/办公室主任
职位描述
l Lead the team to ensure operations process are smoot and to be done within agreed turn-around-time
l To make sure is a high standard of quality and accuracy
l Monitor and control operational performance and the risk reporting is completed on time
l Ensure company policies and procedures are enforced and reviewed regularly
l Assist with prepares annual budgets and any ad-hoc task as assigned by direct line manager
l Manage the overall performance of the team
l Participate in company operation projects, including prepare the action plans, understand the business requirement, testing and implementation.
l Liaise with the internal and external parties to support and implement growth strategies for system improvements.
l Work as an internal QC in Operation Team to ensure the operational compliance.
Any other duties as assigned by management
Education, Qualifications, Skills and Experience 任职要求
- Bachelor Degree or above
- +5 years relevant working experience
- High work efficiency, able to solve emergency and difficulties
- Good command of English and good interpersonal and communication skills
- Excellent project-management experience, willing to take up new duties and meet new challenges Strong self-motivation and ability to work in high pressure environment.
Good knowledge of MS office
职能类别:行政经理/主管/办公室主任
公司介绍
迪哲医药,于2017年10月独立运营,是一家研发驱动型生物医药企业,致力于全球创新药物(First-in-class/ Best-in-class)探索、研发以及商业化。
详情请点击公司官方网站:**************************/
Dizal Pharma
On Nov. 27th, 2017, through a joint venture between AstraZeneca and China Advanced Manufacturing Fund, Dizal Pharma was co-constructed as a world-leading innovative bio-pharmaceutical enterprise. As a new, unique mode of cooperation between SDIC Fund Management Company Ltd. and worldwide privileged research resources in the field of biological pharmacy, Dizal Pharma can not only accelerate the launch and listing of global new drugs in China, bring Chinese patients access to the latest drugs found across the world at once and thus raise the clinical benefits of patients; At the same time, we also take advantages of the global privileged innovative resources, increase China’s core competitive power in the innovation of new drugs, step in the leading branch of international research and development of new drugs and push China into the role of causing both huge and powerful influence in pharmacy industry.
As a new-style joint venture company, besides the project of the transfer of AstraZeneca’s patents, Dizal Pharma also develops the innovation and creation of global First-in-Class drugs.
The R&D (Research and Development) team of Dizal Pharma was AstraZeneca Asia and Emerging Market Research Center. As one of AstraZeneca’s first four R&D centers across the world, it dedicated to analyze the potential scientific mechanism of those most common diseases in Asia and fulfill the particular medical needs of Asian patients. It was one of the few R&D centers established by transnational pharmacy enterprises in China which had the ability to actually research, develop and produce micro-molecular new drugs, the ability to develop produce new drugs independently and completely, and the first-class medical platform in the world.
联系方式
- 公司地址:地址:span亮景路199号